Outsourcing in Clinical Trials DACH 2019
9th – 10th October 2019, Munich, Germany
After an incredibly successful inaugural edition, Outsourcing in Clinical Trials DACH will be taking place in Munich for 2019.
The 2nd annual edition will focus upon the operational challenges in clinical development found within Germany, Austria and Switzerland. Over 2 days, delegates will discuss the common challenges and trends impacting the region, including steps for defining contractual relationships and getting the maximum from external providers, incentivising good relationships with CROs and constructing defined deadlines.
With ideas shared between large and small pharma alongside innovative solution providers, this event will offer interactive, knowledgeable and will be a highlight within the DACH pharma industry calendar. Delegates will enjoy an engaging programme with workshops, panel discussions, roundtables and presentations, whilst exchanging local knowledge on the opportunities for clinical trials in the region.
Registration is now open – book your 2019 ticket today!
WHY TO EXPECT FOR 2019
Join pharma and biotech experts to discuss new trends and opportunities and learn how they optimize their clinical operations enabling you to stay ahead of the game.
Find the right solution providers to partner with, allowing you to accelerate your trial timelines.
WHY THIS IS YOUR UNMISSABLE CONFERENCE
This is an exceptional networking opportunity for industry accelerators. Meet industry C-Suite and Director level executives and make valuable connection at this annual thought leadership platform.
Join like-minded peers to learn new perspectives and case studies through presentation, panel discussions, interactive round tables and workshops.
The conference discusses the vital connections between process, tools and techniques to manage change. Update your knowledge to create new strategies enabling you to enact change.
Inamed is an internationally operating German CRO with special expertise in inhalation medicine. For several years now, we are extending our range of activities. In our Clinical Unit with up to 24 beds + 6 intensive monitoring beds (for FIM study for example) we are able to offer Phase-I study services in a broader context. Beside these activities, Inamed also offers complementary services; our In-vitro Department can characterize your drug delivery device and our Clinical Operations Department can assist you throughout the entire study (consulting on study design, regulatory submission, project management). The study protocol and final report can be established by our own Medical Writing Department. At Inamed, we value the direct contact to our clients and are proud to offer full service solutions.
Dr. Françoise Förstemann and Dr. Susanne Kolbmann, both from BD department, are looking forward meeting you at Booth #25.
Pharm-Olam International delivers cost effective, quality clinical services to pharma and biotech sponsors across all therapeutic areas in more than 40 countries. Since 1994, we have been committed to our objective: to create value for our clients by satisfying their clinical development needs with consistent and dependable solutions and services.
Advanced Clinical is a full-service CRO with flexible FSP and talent management solutions that works in all areas of clinical development including preclinical development, translational medicine, and Phases 1-4. Our flexible solutions are offered through multiple outsourcing models designed meet each specific client’s needs.
CROMSOURCE is an international contract research organization providing a comprehensive services to the pharmaceutical and biotechnology companies. Specializing in clinical development and staffing solutions, we offer a flexible approach to ensure our clients’ unique needs are supported. CROMSOURCE is unparalleled in offering an end-to-end guarantee covering trial timelines, enrollment, and price. CROMSOURCE operates offices across Europe and North America.